Linden LLC

HYCOR Expands Board of Directors

May 16, 2011 | For Immediate Release

Linden Recruits Senior Executives from Quest and Abbott to Support HYCOR’s Growth

Garden Grove, California, (May 16, 2011) – HYCOR Biomedical Inc., a leading manufacturer and marketer of in vitro diagnostic products for the global allergy, autoimmune and urinalysis markets, together with owner Linden LLC, today announced the appointments of Vijay Aggarwal, Ph.D. and James Koziarz, Ph.D., to its Board of Directors.

“We are thrilled to welcome Drs. Aggarwal and Koziarz to our growing team at HYCOR and are confident that they will have an immediate and meaningful impact at our company,” commented Richard Novak, Chairman of HYCOR’s Board of Directors and Operating Partner at Linden LLC. “Each of these gentlemen brings unique and seasoned perspective to our Board, and I am confident HYCOR will benefit from their guidance and insight.”

Dr. Aggarwal brings over 30 years of experience and leadership in the pharmaceutical and clinical diagnostics industries to HYCOR. He has served in senior management and director positions for a number of public and privately held companies, including Quest Diagnostics, IBT Laboratories, and SmithKline Beecham. Dr. Aggarwal will support HYCOR and its management team in a variety of capacities as Director, with a particular focus on channel development in clinical laboratories.

Dr. Koziarz joins HYCOR’s Board after a distinguished 25 year career at Abbott Laboratories, where he held several senior management and executive positions, including Corporate Vice President for Diagnostic Products Research & Development. Dr. Koziarz is also an active advisor to several venture-backed life sciences companies. Dr. Koziarz will focus his collaboration with HYCOR and its management team on next generation assay and platform development strategies for global customers.

“We are pleased to have the opportunity to partner with these two leaders in clinical diagnostics and are confident their leadership will benefit HYCOR and the healthcare professionals and patients our products serve,” said HYCOR CEO Dick Aderman, formerly of Roche Diagnostics and Boehringer Mannheim. “Our executive team has already begun working with each of them on key initiatives currently underway at our company and we look forward to the value they will bring to our business.”